A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders
Recruiting · NCT04793828 · Interventional (participants receive a specific treatment) · Lead sponsor: Charite University, Berlin, Germany
View the official record on ClinicalTrials.gov →Interventions studied
Velibra
What this trial is about
The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder
- Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires
- Written informed consent
- Internet access
Exclusion criteria
- Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder)
- Acute suicidality
- Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)
Where it is running
1 location listed.
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin - Berlin, Germany